These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 24898058)

  • 101. [PARP (poly(ADP-ribose) polymerase) family].
    Saito H; Miki Y
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():71-7. PubMed ID: 23513815
    [No Abstract]   [Full Text] [Related]  

  • 102. Poly(ADP-ribosyl)ation in mammalian ageing.
    Beneke S; Bürkle A
    Nucleic Acids Res; 2007; 35(22):7456-65. PubMed ID: 17913748
    [TBL] [Abstract][Full Text] [Related]  

  • 103. A Poly-ADP-Ribose Polymer-GCSF Conjugate.
    Cheng Q; Zhang XN; Zhang L; Chen J; Wang Y; Zhang Y
    Biomacromolecules; 2022 Dec; 23(12):5267-5272. PubMed ID: 36350184
    [TBL] [Abstract][Full Text] [Related]  

  • 104. DNA fragmentation and NAD depletion. Their relation to the turnover of endogenous mono(ADP-ribosyl) and poly(ADP-ribosyl) proteins.
    Wielckens K; Schmidt A; George E; Bredehorst R; Hilz H
    J Biol Chem; 1982 Nov; 257(21):12872-7. PubMed ID: 6813330
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment.
    Park SR; Chen A
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):649-70, ix. PubMed ID: 22520984
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Regulation of poly(ADP-Ribose) polymerase 1 functions by post-translational modifications.
    Piao L; Fujioka K; Nakakido M; Hamamoto R
    Front Biosci (Landmark Ed); 2018 Jan; 23(1):13-26. PubMed ID: 28930534
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Joining the PARty: PARP Regulation of KDM5A during DNA Repair (and Transcription?).
    Sanchez A; Buck-Koehntop BA; Miller KM
    Bioessays; 2022 Jul; 44(7):e2200015. PubMed ID: 35532219
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The Critical Role of PARPs in Regulating Innate Immune Responses.
    Zhu H; Tang YD; Zhan G; Su C; Zheng C
    Front Immunol; 2021; 12():712556. PubMed ID: 34367175
    [TBL] [Abstract][Full Text] [Related]  

  • 109. ADP-ribosylation: activation, recognition, and removal.
    Li N; Chen J
    Mol Cells; 2014 Jan; 37(1):9-16. PubMed ID: 24552704
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic biomarkers.
    Redon CE; Nakamura AJ; Zhang YW; Ji JJ; Bonner WM; Kinders RJ; Parchment RE; Doroshow JH; Pommier Y
    Clin Cancer Res; 2010 Sep; 16(18):4532-42. PubMed ID: 20823146
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Modeling pharmacodynamic response to the poly(ADP-Ribose) polymerase inhibitor ABT-888 in human peripheral blood mononuclear cells.
    Ji J; Kinders RJ; Zhang Y; Rubinstein L; Kummar S; Parchment RE; Tomaszewski JE; Doroshow JH
    PLoS One; 2011; 6(10):e26152. PubMed ID: 22028822
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Why structure and chain length matter: on the biological significance underlying the structural heterogeneity of poly(ADP-ribose).
    Reber JM; Mangerich A
    Nucleic Acids Res; 2021 Sep; 49(15):8432-8448. PubMed ID: 34302489
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases.
    Morales J; Li L; Fattah FJ; Dong Y; Bey EA; Patel M; Gao J; Boothman DA
    Crit Rev Eukaryot Gene Expr; 2014; 24(1):15-28. PubMed ID: 24579667
    [TBL] [Abstract][Full Text] [Related]  

  • 114. A PARP1-TIMELESS alliance in cancer therapy.
    Tarsounas M
    Mol Cell; 2024 May; 84(10):1824-1825. PubMed ID: 38759623
    [TBL] [Abstract][Full Text] [Related]  

  • 115. A desthiobiotin labelled NAD
    Rieth S; Spliesgar D; Orth J; Lehner M; Kasprzyk R; Stengel F; Marx A
    Chembiochem; 2024 Mar; 25(5):e202300797. PubMed ID: 38236015
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts.
    Daugherty MD; Young JM; Kerns JA; Malik HS
    PLoS Genet; 2014; 10(5):e1004403. PubMed ID: 24875882
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Regulation of Biomolecular Condensates by Poly(ADP-ribose).
    Rhine K; Odeh HM; Shorter J; Myong S
    Chem Rev; 2023 Jul; 123(14):9065-9093. PubMed ID: 37115110
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Development and characterization of new tools for detecting poly(ADP-ribose) in vitro and in vivo.
    Challa S; Ryu KW; Whitaker AL; Abshier JC; Camacho CV; Kraus WL
    Elife; 2022 Apr; 11():. PubMed ID: 35476036
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains.
    Egloff MP; Malet H; Putics A; Heinonen M; Dutartre H; Frangeul A; Gruez A; Campanacci V; Cambillau C; Ziebuhr J; Ahola T; Canard B
    J Virol; 2006 Sep; 80(17):8493-502. PubMed ID: 16912299
    [TBL] [Abstract][Full Text] [Related]  

  • 120. PARP-nucleic acid interactions: Allosteric signaling, PARP inhibitor types, DNA bridges, and viral RNA surveillance.
    Pascal JM
    Curr Opin Struct Biol; 2023 Aug; 81():102643. PubMed ID: 37352603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.